Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Construction in Progress (2017 - 2018)

Abeona Therapeutics (ABEO) has 2 years of Construction in Progress data on record, last reported at $409000.0 in Q4 2018.

  • For Q4 2018, Construction in Progress fell 10.11% year-over-year to $409000.0; the TTM value through Dec 2018 reached $409000.0, down 10.11%, while the annual FY2018 figure was $409000.0, 10.11% down from the prior year.
  • Construction in Progress reached $409000.0 in Q4 2018 per ABEO's latest filing, down from $455000.0 in the prior quarter.
  • Across five years, Construction in Progress topped out at $455000.0 in Q4 2017 and bottomed at $409000.0 in Q4 2018.